Purchase Order AG3K06P120060
- Not listed
- This is a firm fixed-price delivery order awarded by the National Institute of Environmental Health Sciences, a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $78,703.47 contract is not associated with a set-aside. Illumina has previously received prime and subcontract awards from federal agencies such as the NIH, CDC, USDA, and VA to provide sequencing instruments, consumables, and bioinformatics support for genomic research and diagnostic...
- This is a $127,989.57 firm fixed-price delivery order awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing technologies. The contract has a period of performance ending on July 30, 2026. Illumina, a for-profit manufacturer, has been awarded multiple federal contracts and blanket purchase agreements to provide a range of genomic sequencing platforms,...
- This is a firm fixed-price delivery order issued by the National Institute on Aging, a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract has a ceiling value of $23,879.80 and an ultimate completion date of July 7, 2025. The contract is for the procurement of Illumina's TruSeq Stranded Total RNA Library Prep Gold and NovaSeq X Series 10B Reagent Kits, which are biological and reagent products used in genomic sequencing...
- This is a firm fixed-price delivery order awarded by the National Institute on Aging, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $872,996.22 award is for the provision of Illumina reagent kits to support genomic analysis and sequencing work. This order falls under a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy's Bureau of Medicine and...
- This is a firm-fixed-price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The $60,625.54 contract is for the procurement of Illumina's genetic sequencing platforms, reagents, consumables, and related services. The award does not utilize any set-aside designations. Illumina is a leading manufacturer of advanced genomic sequencing technologies and has been awarded...
- This firm fixed-price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The $500,000.00 contract is for the supply of Illumina sequencing systems, reagents, and related services to support genomic sequencing and analysis research and applications across federal agencies. Illumina has been awarded multiple prime federal contracts and...
- This is a $19,812.90 firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract has an ultimate completion date of August 3, 2026 and was awarded on August 4, 2025. No set-aside designation was used. Illumina, a leading provider of DNA and RNA sequencing technologies, will deliver a range...
- This firm fixed-price purchase order for $50,445.50 was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of reagent kits and has a completion date of September 29, 2023. The contract was competitively awarded with no set-aside designation. Illumina has previously provided...
- This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit organization and manufacturer of sequencing and genomic analysis solutions. The contract, valued at $112,216.00, is for the purchase of Illumina's sequencing systems, reagents, and other products to support genomic research and diagnostics. The contract is a firm fixed price purchase order with no set-aside designation....
- This is a $285,200.00 firm fixed price contract awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Illumina, Inc. for the provision of a DNA sequencer. The contract has no set-aside designation and was awarded on July 27, 2015, with a final completion date of November 24, 2015. Illumina, a for-profit manufacturer of genomic analysis instruments and reagents, has a history of providing sequencing systems and associated products to support research and diagnostics...
This is a firm fixed-price purchase order awarded by a civilian federal agency to Illumina, Inc., a for-profit manufacturer of genetic sequencing technologies. The $47,945.52 contract is for kitted reagents to prepare DNA sequencing libraries and complete four instrument runs using Illumina's HiSeq2000 DNA sequencer, generating 200 base pairs of sequence data per molecule. The award is not associated with a set-aside designation or a larger federal contract vehicle. Illumina has been awarded multiple contracts from federal agencies, including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Department of Agriculture (USDA), and Department of Veterans Affairs (VA), to provide a range of advanced genomic sequencing platforms, reagents, and related services to support scientific research and diagnostic applications across the government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 1 | Other Administrative Action | ($1k) | 10/31/16 | |
| Not listed | Not listed | $48.9k | 11/29/11 |